Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 101.24%2.56B | 80.45%1.27B | 219.34M | 36.41%703.61M | 515.79M |
| Cost of revenue | 241.67%1.44B | 217.54%420.18M | 93.73M | 72.90%132.33M | 76.53M |
| Gross profit | 31.78%1.12B | 48.69%849.44M | 125.61M | 30.06%571.28M | 439.26M |
| Operating expense | 18.41%506.42M | 26.48%427.69M | 135.62M | 15.34%338.13M | 293.17M |
| Selling and administrative expenses | 18.19%506.42M | 26.72%428.49M | --135.33M | 15.34%338.13M | --293.17M |
| -General and administrative expense | 18.19%506.42M | 26.72%428.49M | --135.33M | 15.34%338.13M | --293.17M |
| Other operating expenses | ---- | ---803K | --282K | ---- | ---- |
| Operating profit | 45.34%613M | 80.90%421.76M | -10.01M | 59.59%233.15M | 146.09M |
| Net non-operating interest income (expenses) | 139.35%1.32M | -2,321.74%-3.34M | -837K | -236.59%-138K | -41K |
| Non-operating interest income | 9,454.55%2.1M | 1,000.00%22K | --20K | -33.33%2K | --3K |
| Non-operating interest expense | -76.61%787K | 2,302.86%3.36M | --857K | 218.18%140K | --44K |
| Net investment income | -21K | -80K | -43K | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||
| Income from associates and other participating interests | |||||
| Special income (charges) | 92.02%23.74M | 12.36M | 0 | 0 | |
| Less:Impairment of capital assets | --0 | --16.94M | --0 | --0 | ---- |
| Less:Other special charges | 18.99%-23.74M | ---29.3M | --0 | ---- | ---- |
| Other non-operating income (expenses) | -682.57%-15.71M | -223.34%-2.01M | -2.02M | 53.58%1.63M | 1.06M |
| Income before tax | 45.14%622.34M | 82.74%428.77M | -12.92M | 59.55%234.64M | 147.06M |
| Income tax | 25.90%176.63M | 96.81%140.29M | -17.86M | 48.20%71.28M | 48.1M |
| Net income | 54.50%445.71M | 76.59%288.48M | 4.94M | 65.06%163.36M | 98.97M |
| Net income continuous operations | 54.50%445.71M | 76.59%288.48M | --4.94M | 65.06%163.36M | --98.97M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 54.50%445.71M | 76.59%288.48M | 4.94M | 65.06%163.36M | 98.97M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 54.50%445.71M | 76.59%288.48M | 4.94M | 65.06%163.36M | 98.97M |
| Gross dividend payment | |||||
| Basic earnings per share | 31.04%110.46 | 76.35%84.2942 | 14.5079 | 96.24%47.7994 | 24.3579 |
| Diluted earnings per share | 22.13%102.95 | 76.35%84.2942 | 1.2146 | 96.24%47.7994 | 24.3579 |
| Dividend per share | 20 | ||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |